Status:
COMPLETED
Adiponectin and Insulin Resistance in Diabetic Nephropathy
Lead Sponsor:
Xi'an Jiaotong University
Collaborating Sponsors:
Shanghai Jiao Tong University School of Medicine
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by antihypertensive medication with an angiotensin II-rece...
Eligibility Criteria
Inclusion
- Type 2 diabetic nephropathy
- CKD at stage 1\~4
Exclusion
- Type 1 diabetes or nondiabetic renal disease
- An elevated plasma K level.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00774904
Start Date
April 1 2007
End Date
November 1 2007
Last Update
October 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai No.3 people's hospital
Shanghai, China, 201900